Holen Sie sich die Stockscreener-App
8.60
1.30%
0.11
Schlusskurs vom Vortag:
$8.49
Offen:
$8.25
24-Stunden-Volumen:
139.79K
Relative Volume:
2.06
Marktkapitalisierung:
$186.59M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+3.61%
1M Leistung:
-31.47%
6M Leistung:
-24.43%
1J Leistung:
+0.00%
1-Tages-Spanne:
$8.25
$8.99
1-Wochen-Bereich:
$8.03
$9.09
52-Wochen-Spanne:
$4.88
$19.58
Aardvark Therapeutics Inc Stock (AARD) Company Profile
Firmenname
Aardvark Therapeutics Inc
Sektor
Branche
Telefon
(858) 225-7696
Adresse
4370 LA JOLLA VILLAGE DRIVE, SAN DIEGO
Vergleichen Sie AARD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AARD
Aardvark Therapeutics Inc
|
8.60 | 184.17M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Aardvark Therapeutics Inc Stock (AARD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-03-10 | Eingeleitet | BofA Securities | Buy |
| 2025-03-10 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-03-10 | Eingeleitet | Morgan Stanley | Overweight |
| 2025-03-10 | Eingeleitet | RBC Capital Mkts | Outperform |
Aardvark Therapeutics Inc Aktie (AARD) Neueste Nachrichten
Developing predictive dashboards with Aardvark Therapeutics Inc. dataEarnings Miss & Breakout Confirmation Alerts - Newser
What MACD signals say about Aardvark Therapeutics Inc.July 2025 Breakouts & Fast Gain Swing Alerts - Newser
Candlestick signals on Aardvark Therapeutics Inc. stock today2025 Biggest Moves & Fast Moving Market Watchlists - Newser
Can volume confirm reversal in Aardvark Therapeutics Inc.2025 Historical Comparison & AI Driven Stock Movement Reports - Newser
Aardvark Therapeutics Inc. stock chart pattern explainedOil Prices & Free Technical Pattern Based Buy Signals - Newser
Real time breakdown of Aardvark Therapeutics Inc. stock performanceJuly 2025 Opening Moves & Verified Chart Pattern Signals - Newser
Custom watchlist performance reports with Aardvark Therapeutics Inc.Sell Signal & Precise Swing Trade Entry Alerts - Newser
Is Aardvark Therapeutics Inc. a candidate for recovery play2025 Dividend Review & Free High Accuracy Swing Entry Alerts - Newser
Is Aardvark Therapeutics Inc. stock a smart retirement pickEarnings Recap Summary & Safe Capital Growth Plans - خودرو بانک
Will Aardvark Therapeutics Inc. stock recover after earningsJuly 2025 Technicals & Community Consensus Stock Picks - خودرو بانک
Can Aardvark Therapeutics Inc. recover in the next quarterJuly 2025 Institutional & High Accuracy Buy Signal Tips - Newser
What high frequency data says about Aardvark Therapeutics Inc.Options Play & Low Volatility Stock Recommendations - Newser
Will Aardvark Therapeutics Inc. stock go up soonJuly 2025 Rallies & Short-Term High Return Strategies - Newser
Statistical indicators supporting Aardvark Therapeutics Inc.’s strengthOil Prices & Consistent Growth Equity Picks - Newser
Aardvark Therapeutics Inc. stock daily chart insightsJuly 2025 Patterns & Free Community Consensus Stock Picks - Newser
How to build a custom watchlist for Aardvark Therapeutics Inc.July 2025 Levels & Real-Time Stock Movement Alerts - Newser
Is Aardvark Therapeutics Inc. stock showing strong momentum2025 Sector Review & Expert-Curated Trade Recommendations - خودرو بانک
What’s next for Aardvark Therapeutics Inc. stock priceJuly 2025 Chart Watch & Low Drawdown Momentum Trade Ideas - Newser
Aardvark Therapeutics reports inducement grants under Nasdaq listing rule - TipRanks
Will Aardvark Therapeutics Inc. bounce back from current supportJuly 2025 Intraday Action & Daily Stock Trend Reports - Newser
How to forecast Aardvark Therapeutics Inc. trends using time seriesTrade Risk Assessment & Community Verified Trade Signals - Newser
Aardvark Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - The Manila Times
Can machine learning forecast Aardvark Therapeutics Inc. recoveryMarket Performance Recap & Stock Portfolio Risk Management - Newser
Tick level data insight on Aardvark Therapeutics Inc. volatilityPortfolio Gains Report & Risk Controlled Daily Plans - Newser
Tools to assess Aardvark Therapeutics Inc.’s risk profileJuly 2025 Sector Moves & Breakout Confirmation Alerts - Newser
Is Aardvark Therapeutics Inc. stock overvalued or fairly pricedJuly 2025 Summary & Verified Entry Point Detection - خودرو بانک
Aardvark Therapeutics (AARD): Pioneering Gut-Brain Signaling to Disrupt Obesity and Metabolic Disease Therapies - AInvest
Aardvark Therapeutics’ Strategic Position in Metabolic Disease Innovation - AInvest
Should you buy the dip on Aardvark Therapeutics Inc.July 2025 Rallies & Expert-Curated Trade Recommendations - خودرو بانک
Combining machine learning predictions for Aardvark Therapeutics Inc.Gold Moves & Verified Momentum Stock Alerts - Newser
Aardvark Therapeutics Updates Corporate Presentation on Strategy - TipRanks
Can Aardvark Therapeutics Inc. continue delivering strong returns2025 Dividend Review & Trade Opportunity Analysis Reports - خودرو بانک
Does Aardvark Therapeutics Inc. offer margin of safetyQuarterly Profit Report & Smart Swing Trading Techniques - خودرو بانک
Should I average down on Aardvark Therapeutics Inc. stock2025 Market Trends & Fast Moving Stock Trade Plans - خودرو بانک
Is Aardvark Therapeutics Inc. stock a good dividend stockJuly 2025 Update & Growth Focused Entry Reports - خودرو بانک
Will Aardvark Therapeutics Inc. outperform its industry peersOil Prices & Daily Stock Trend Watchlist - خودرو بانک
Analyzing Aardvark Therapeutics Inc. with risk reward ratio chartsMarket Sentiment Review & Safe Capital Allocation Plans - Newser
Finanzdaten der Aardvark Therapeutics Inc-Aktie (AARD)
Es liegen keine Finanzdaten für Aardvark Therapeutics Inc (AARD) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
Aardvark Therapeutics Inc-Aktie (AARD) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Lee Tien-Li | Chief Executive Officer |
Aug 28 '25 |
Option Exercise |
4.24 |
17,209 |
72,966 |
1,513,384 |
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):